Clinical Microbiology Newsletter
Volume 30, Issue 16 , Pages 124-125 , 15 August 2008

Bacteremia Caused by an Extended-Spectrum Beta-Lactamase-Producing Alcaligenes faecalis Strain

  • R. Naesens, M.D.

      Affiliations

    • Department of Microbiology, GZA Sint-Augustinus, Wilrijk, Belgium
    • Corresponding Author InformationMailing Address: Reinout Naesens, M.D., Laboratory of Microbiology, GZA Sint-Augustinus, Oosterveldlaan 24, 2610 Wilrijk Belgium. Tel.: 0032/11 22 17 49. Fax: 0032/51 21 15 86
    • ,
  • J. Van Leemput, M.D.

      Affiliations

    • Department of Intensive Care Medicine, GZA Sint-Augustinus, Wilrijk, Belgium
    • ,
  • J. Raemaekers, M.D.

      Affiliations

    • Department of Intensive Care Medicine, GZA Sint-Augustinus, Wilrijk, Belgium
    • ,
  • J. Van Schaeren, M.D.

      Affiliations

    • Department of Microbiology, GZA Sint-Augustinus, Wilrijk, Belgium
    • ,
  • A. Jeurissen, M.D., Ph.D.

      Affiliations

    • Department of Microbiology, GZA Sint-Augustinus, Wilrijk, Belgium

References 

  1. Bizet J , Bizet C . Strains of Alcaligenes faecalis from clinical material . J. Infect. . 1997;35:167–169
  2. Bruckner DA , Colonna P , Bearson BL . Nomenclature for aerobic and facultative bacteria . Clin. Infect. Dis. . 1999;29:713–723
  3. Wilson WR , Van Scoy RE , Washington JA . Incidence of bacteremia in adults without infection . J. Clin. Microbiol. . 1976;2:94–95
  4. Aisenberg G , Rolston KV , Safdar A . Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003) . Cancer . 2004;101:2134–2140
  5. Kaliaperumal S , et al.   Postoperative endophthalmitis due to an unusual pathogen: Alcaligenes faecalis . Eye . 2006;20:968–969
  6. Skegg DC . Alcaligenes faecalis septicaemia . N. Z. Med. J. . 1976;83:117–118
  7. Pereira M , et al.   PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy . Microb. Drug Resist. . 2000;6:85–90
  8. Dubois V , et al.   TEM-21 extended-spectrum beta-lactamase in a clinical isolate of Alcaligenes faecalis from a nursing home . J. Antimicrob. Chemother. . 2006;57:368–369
  9. Paterson DL , Bonomo RA . Extended-spectrum β-lactamases: a clinical update . Clin. Microbiol. Rev. . 2005;18:657–686
  10. Ramphal R , Ambrose PG . Extended-spectrum β-lactamases and clinical outcomes: current data . Clin. Infect. Dis. . 2006;42:164–172

PII: S0196-4399(08)00040-8

doi: 10.1016/j.clinmicnews.2008.07.005

Clinical Microbiology Newsletter
Volume 30, Issue 16 , Pages 124-125 , 15 August 2008

Article Tools